These findings are important because of the central role of PSA testing in the diagnosis of prostate cancer, which leads to the possibility that associations reported between risk factors and prostate cancer in observational studies could be affected by detection bias (i.e. factors that are associated with men choosing to undergo PSA testing will, in turn, be associated with increased prostate cancer incidence). Here, KLK3 is linked to prostate carcinoma.